<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Nephrology Now &#187; Editorial</title>
	<atom:link href="http://www.nephrologynow.com/publications/category/editorial/feed" rel="self" type="application/rss+xml" />
	<link>http://www.nephrologynow.com</link>
	<description></description>
	<lastBuildDate>Tue, 20 Jul 2010 07:46:28 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<script type="text/javascript">

if (typeof Meebo == 'undefined') {

Meebo=function(){(Meebo._=Meebo._||[]).push(arguments)};
(function(q){

	var args = arguments;
	if (!document.body) { return setTimeout(function(){ args.callee.apply(this, args) }, 100); }
	var d=document, b=d.body, m=b.insertBefore(d.createElement('div'), b.firstChild); s=d.createElement('script');
	m.id='meebo'; m.style.display='none'; m.innerHTML='<iframe id="meebo-iframe"></iframe>';
	s.src='http'+(q.https?'s':'')+'://'+(q.stage?'stage-':'')+'cim.meebo.com/cim/cim.php?network='+q.network;
	b.insertBefore(s, b.firstChild);

})({network:'nephrologynow_bi16va'});	}</script>	<item>
		<title>The Initiation of Renal-Replacement Therapy — Just-in-Time Delivery</title>
		<link>http://www.nephrologynow.com/publications/the-initiation-of-renal-replacement-therapy-%e2%80%94-just-in-time-delivery</link>
		<comments>http://www.nephrologynow.com/publications/the-initiation-of-renal-replacement-therapy-%e2%80%94-just-in-time-delivery#comments</comments>
		<pubDate>Mon, 28 Jun 2010 05:52:44 +0000</pubDate>
		<dc:creator>Nephrology Now editors</dc:creator>
				<category><![CDATA[Editorial]]></category>
		<category><![CDATA[Hemodialysis]]></category>
		<category><![CDATA[Peritoneal Dialysis]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com/?p=1513</guid>
		<description><![CDATA[This editorial provides insight into the interpretation of the article &#8216;A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis&#8216;.Related Articles:

A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis
Treatment of Anemia in Chronic Kidney Disease — Strategies Based on Evidence
Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: [...]]]></description>
			<content:encoded><![CDATA[<p>This editorial provides insight into the interpretation of the article &#8216;<a href="http://content.nejm.org/cgi/content/full/NEJMoa1000552">A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis</a>&#8216;.<strong>Related Articles:</strong>
<ul class="similar-posts">
<li><a href="http://www.nephrologynow.com/publications/a-randomized-controlled-trial-of-early-versus-late-initiation-of-dialysis" rel="bookmark" title="June 27, 2010">A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis</a></li>
<li><a href="http://www.nephrologynow.com/publications/treatment-of-anemia-in-chronic-kidney-disease-%e2%80%94-strategies-based-on-evidence" rel="bookmark" title="October 31, 2009">Treatment of Anemia in Chronic Kidney Disease — Strategies Based on Evidence</a></li>
<li><a href="http://www.nephrologynow.com/publications/low-gdp-fluid-gambrosol-trio%c2%ae-attenuates-decline-of-residual-renal-function-in-pd-patients-a-prospective-randomized-study" rel="bookmark" title="May 1, 2010">Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study</a></li>
</ul>
<p><!-- Similar Posts took 7.147 ms --></p>
<img style='display:none' id="post-1513-blankimage" onload="Meebo('discoverSharable', {element: ((this.parentNode.className.match('post')) ? this.parentNode : this.parentNode.parentNode) ,url:'http://www.nephrologynow.com/publications/the-initiation-of-renal-replacement-therapy-%e2%80%94-just-in-time-delivery',title:'The Initiation of Renal-Replacement Therapy — Just-in-Time Delivery',tweet:'This editorial provides insight into the interpretation of the article &#8216;A Randomized, Controll',description:'This editorial provides insight into the interpretation of the article &#8216;A Randomized, Controll'})"><script type='text/javascript'></script>]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/the-initiation-of-renal-replacement-therapy-%e2%80%94-just-in-time-delivery/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Erythropoiesis-Stimulating Agents — Time for a Reevaluation</title>
		<link>http://www.nephrologynow.com/publications/erythropoiesis-stimulating-agents-%e2%80%94-time-for-a-reevaluation</link>
		<comments>http://www.nephrologynow.com/publications/erythropoiesis-stimulating-agents-%e2%80%94-time-for-a-reevaluation#comments</comments>
		<pubDate>Tue, 12 Jan 2010 01:09:06 +0000</pubDate>
		<dc:creator>Nephrology Now editors</dc:creator>
				<category><![CDATA[Anemia]]></category>
		<category><![CDATA[Editorial]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com/?p=1332</guid>
		<description><![CDATA[This NEJM &#8220;Perspectives&#8221; article from the Food and Drug Administration discusses the data driving a need to re-evaluate the use of ESAs in the treatment of anemia due to chronic kidney disease.Related Articles:

The FDA&#8217;s Perspective on the Risk for Rapid Rise in Hemoglobin in Treating CKD Anemia: Quo Vadis
Stage IV Chronic Kidney Disease
Does TREAT Give [...]]]></description>
			<content:encoded><![CDATA[<p>This NEJM &#8220;Perspectives&#8221; article from the Food and Drug Administration discusses the data driving a need to re-evaluate the use of ESAs in the treatment of anemia due to chronic kidney disease.<strong>Related Articles:</strong>
<ul class="similar-posts">
<li><a href="http://www.nephrologynow.com/publications/the-fdas-perspective-on-the-risk-for-rapid-rise-in-hemoglobin-in-treating-ckd-anemia-quo-vadis" rel="bookmark" title="May 1, 2010">The FDA&#8217;s Perspective on the Risk for Rapid Rise in Hemoglobin in Treating CKD Anemia: Quo Vadis</a></li>
<li><a href="http://www.nephrologynow.com/publications/stage-iv-chronic-kidney-disease" rel="bookmark" title="January 11, 2010">Stage IV Chronic Kidney Disease</a></li>
<li><a href="http://www.nephrologynow.com/publications/does-treat-give-the-boot-to-esas-in-the-treatment-of-ckd-anemia" rel="bookmark" title="January 11, 2010">Does TREAT Give the Boot to ESAs in the Treatment of CKD Anemia?</a></li>
</ul>
<p><!-- Similar Posts took 29.061 ms --></p>
<img style='display:none' id="post-1332-blankimage" onload="Meebo('discoverSharable', {element: ((this.parentNode.className.match('post')) ? this.parentNode : this.parentNode.parentNode) ,url:'http://www.nephrologynow.com/publications/erythropoiesis-stimulating-agents-%e2%80%94-time-for-a-reevaluation',title:'Erythropoiesis-Stimulating Agents — Time for a Reevaluation',tweet:'This NEJM &#8220;Perspectives&#8221; article from the Food and Drug Administration discusses the dat',description:'This NEJM &#8220;Perspectives&#8221; article from the Food and Drug Administration discusses the dat'})"><script type='text/javascript'></script>]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/erythropoiesis-stimulating-agents-%e2%80%94-time-for-a-reevaluation/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Does TREAT Give the Boot to ESAs in the Treatment of CKD Anemia?</title>
		<link>http://www.nephrologynow.com/publications/does-treat-give-the-boot-to-esas-in-the-treatment-of-ckd-anemia</link>
		<comments>http://www.nephrologynow.com/publications/does-treat-give-the-boot-to-esas-in-the-treatment-of-ckd-anemia#comments</comments>
		<pubDate>Tue, 12 Jan 2010 01:08:03 +0000</pubDate>
		<dc:creator>Nephrology Now editors</dc:creator>
				<category><![CDATA[Anemia]]></category>
		<category><![CDATA[Chronic Kidney Disease]]></category>
		<category><![CDATA[Editorial]]></category>

		<guid isPermaLink="false">http://www.nephrologynow.com/?p=1328</guid>
		<description><![CDATA[This editorial by Dr. Ajay Singh discusses the implications of TREAT in the context of the existing evidence base on the management of anemia due to chronic kidney disease.Related Articles:

The FDA&#8217;s Perspective on the Risk for Rapid Rise in Hemoglobin in Treating CKD Anemia: Quo Vadis
Treatment of Anemia in Chronic Kidney Disease — Strategies Based [...]]]></description>
			<content:encoded><![CDATA[<p>This editorial by Dr. Ajay Singh discusses the implications of TREAT in the context of the existing evidence base on the management of anemia due to chronic kidney disease.<strong>Related Articles:</strong>
<ul class="similar-posts">
<li><a href="http://www.nephrologynow.com/publications/the-fdas-perspective-on-the-risk-for-rapid-rise-in-hemoglobin-in-treating-ckd-anemia-quo-vadis" rel="bookmark" title="May 1, 2010">The FDA&#8217;s Perspective on the Risk for Rapid Rise in Hemoglobin in Treating CKD Anemia: Quo Vadis</a></li>
<li><a href="http://www.nephrologynow.com/publications/treatment-of-anemia-in-chronic-kidney-disease-%e2%80%94-strategies-based-on-evidence" rel="bookmark" title="October 31, 2009">Treatment of Anemia in Chronic Kidney Disease — Strategies Based on Evidence</a></li>
<li><a href="http://www.nephrologynow.com/publications/erythropoiesis-stimulating-agents-%e2%80%94-time-for-a-reevaluation" rel="bookmark" title="January 11, 2010">Erythropoiesis-Stimulating Agents — Time for a Reevaluation</a></li>
</ul>
<p><!-- Similar Posts took 5.271 ms --></p>
<img style='display:none' id="post-1328-blankimage" onload="Meebo('discoverSharable', {element: ((this.parentNode.className.match('post')) ? this.parentNode : this.parentNode.parentNode) ,url:'http://www.nephrologynow.com/publications/does-treat-give-the-boot-to-esas-in-the-treatment-of-ckd-anemia',title:'Does TREAT Give the Boot to ESAs in the Treatment of CKD Anemia?',tweet:'This editorial by Dr. Ajay Singh discusses the implications of TREAT in the context of the existing ',description:'This editorial by Dr. Ajay Singh discusses the implications of TREAT in the context of the existing '})"><script type='text/javascript'></script>]]></content:encoded>
			<wfw:commentRss>http://www.nephrologynow.com/publications/does-treat-give-the-boot-to-esas-in-the-treatment-of-ckd-anemia/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
